| 3/21/2024 | 3002150000 | IMMUNOONCLOGICAL DRUG TRASZEPTIN. INTERNATIONAL NONPROPRIETARY NAME - TRASTUZUMAB, DOSAGE FORM - LYOPHILISATE FOR THE PREPARATION OF A CONCENTRATE FOR THE PREPARATION OF A SOLUTION FOR INFUSIONS 440 MG. VIAL OF | XXXXXXXXXX | 2 | N/A | 0 | Algeria | ALGIERS |
| 3/21/2024 | 3002150000 | IMMUNOLOGICAL PRODUCTS PACKAGED IN FORMS FOR RETAIL SALE: INN (INTERNATIONAL NONPROPRIETARY NAME) TRASTUZUMAB, IMMUNO-ONCOLOGICAL DRUG FOR THE TREATMENT OF MALIGNANT TUMORS, TRADE NAME | XXXXXXXXXX | 1 | N/A | 627283.52 | United Arab Emirates | MOSCOW |
| 3/21/2024 | 3002150000 | IMMUNOLOGICAL PRODUCTS PACKAGED IN RETAIL FORMS: INN (INTERNATIONAL NONPROPRIETARY NAME) - RITUXIMAB, 10 MG/ML, IMMUNO-ONCOLOGICAL DRUG FOR THE TREATMENT OF MALIGNANT TUMORS, TRADE NAME | XXXXXXXXXX | 1 | N/A | 82022.04 | United Arab Emirates | MOSCOW |
| 2/21/2024 | 3002150000 | IMMUNOLOGICAL PRODUCTS PACKAGED IN RETAIL FORMS: INN (INTERNATIONAL NONPROPRIETARY NAME) - RITUXIMAB. IMMUNO-ONCOLOGICAL DRUG FOR THE TREATMENT OF MALIGNANT TUMORS, TRADE NAME RITUXIMAB- | XXXXXXXXXX | 0 | N/A | 78947.87 | Algeria | MOSCOW |
| 2/21/2024 | 3002150000 | IMMUNOLOGICAL PRODUCTS PACKAGED IN RETAIL FORMS: INN (INTERNATIONAL NONPROPRIETARY NAME) - BEVACIZUMAB. IMMUNO-ONCOLOGICAL DRUG FOR THE TREATMENT OF MALIGNANT TUMORS, TRADE NAME BEVACIZUMAB- | XXXXXXXXXX | 0 | N/A | 1178306.31 | Algeria | MOSCOW |
| 10/23/2023 | 3002150000 | IMMUNO-ONCOLOGY DRUG BCD-132 DIVOZILIMAB (AND RELATED PLACEBO). USED IN MULTIPLE SCLEROSIS. INTERNATIONAL NOT | XXXXXXXXXX | 0 | 0 | 28568.1 | India | BANGALORE |
| 8/28/2023 | 3002150000 | IMMUNO-ONCOLOGICAL DRUG FOR THE TREATMENT OF MALIGNANT TUMOR BCD-100 (PROLGOLIMAB), INTERNATIONAL NON-PROPENTED NAME - P | XXXXXXXXXX | 0 | 0 | 4200 | India | MUMBAI |
| 4/7/2023 | 3002150000 | IMMUNO-ONCOLOGICAL DRUG FOR THE TREATMENT OF MALIGNANT TUMORS BCD-201/KEYTRUDA, INTERNATIONAL NON-PROPENTED NAME - PEMBRO | XXXXXXXXXX | 0 | 0 | 248 | Pakistan | LAHORE |
| 4/7/2023 | 3002150000 | IMMUNO-ONCOLOGICAL DRUG FOR THE TREATMENT OF MALIGNANT TUMORS BCD-201, INTERNATIONAL NON-PROPENTED NAME - PEMBROLIZUMAB, | XXXXXXXXXX | 0 | 0 | 300 | Pakistan | LAHORE |
| 4/7/2023 | 3002150000 | IMMUNO-ONCOLOGICAL DRUG FOR THE TREATMENT OF MALIGNANT TUMORS BCD-201/KEYTRUDA, INTERNATIONAL NON-PROPENTED NAME - PEMBRO | XXXXXXXXXX | 0 | 0 | 248 | Pakistan | LAHORE |